| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Throughout the last three months, 5 analysts have evaluated Ameren (NYSE:AEE), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $77.2, a high estimate of $89.00, and a low estimate of $72.00. This current average has decreased by 1.34% from the previous average price target of $78.25.
A clear picture of Ameren's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| James Thalacker | BMO Capital | Raises | Outperform | $76.00 | $75.00 |
| Eric Beaumont | Barclays | Raises | Equal-Weight | $72.00 | $71.00 |
| Julien Dumoulin-Smith | B of A Securities | Announces | Neutral | $77.00 | - |
| Anthony Crowdell | Mizuho | Lowers | Neutral | $72.00 | $77.00 |
| Jeremy Metz | JP Morgan | Lowers | Overweight | $89.00 | $90.00 |
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ameren's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Ameren analyst ratings.
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves more than 2.4 million electricity customers and more than 900,000 natural gas customers.
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining Ameren's financials over 3 months reveals challenges. As of 30 September, 2023, the company experienced a decline of approximately -10.67% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Utilities sector.
Net Margin: Ameren's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 23.93% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.54%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Ameren's ROA stands out, surpassing industry averages. With an impressive ROA of 1.26%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.45, Ameren adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AEE
